Treatment of hiv-associated immune thrombocytopenic purpura

Details Treatment of hiv-associated immune thrombocytopenic purpura Treatment of hiv-associated immune thrombocytopenic purpura

A - Human Necessities

61

K

A61K 39/42 (2006.01) A61K 39/21 (2006.01) C07K 14/73 (2006.01) C07K 16/00 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2108580

2108580 9221755 PCTABS00017 The invention relates to a method for treating HIV-associated immune thrombocytopenic purpura (ITP) which comprises administering to a patient in need of such treatment a therapeutically effective amount of a molecule comprising an amino acid sequence capable of binding to HIV.

Affiliated with

Also associated with

Rating

Treatment of hiv-associated immune thrombocytopenic purpura does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of hiv-associated immune thrombocytopenic purpura, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of hiv-associated immune thrombocytopenic purpura will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1697175